📰 Sciences Ltd News
Page 6 - Sciences Ltd News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Sciences Ltd. Real-time updates on events, politics, business and more.
August 4, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) has earned an average recommendation of “Moderate Buy” from the eight brokerages that are presently covering the company, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price among […]
August 3, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 117,372 shares of the stock in a transaction dated Monday, July 31st. The stock was sold at an average price of $11.91, for a total value of $1,397,900.52. Following the sale, the chief operating officer now directly owns 627,918 shares in the company, […]
August 3, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 16,397 shares of the company’s stock in a transaction that occurred on Wednesday, August 2nd. The stock was sold at an average price of $11.86, for a total transaction of $194,468.42. Following the completion of the sale, the chief operating officer now directly […]
July 28, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 73,568 shares of the stock in a transaction on Wednesday, July 26th. The shares were sold at an average price of $10.91, for a total value of $802,626.88. Following the sale, the chief operating officer now directly owns 627,918 shares in the company, […]
July 26, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 33,081 shares of Roivant Sciences stock in a transaction on Monday, July 24th. The stock was sold at an average price of $10.93, for a total transaction of $361,575.33. Following the transaction, the chief operating officer now directly owns 644,215 shares of the […]
July 25, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 33,081 shares of Roivant Sciences stock in a transaction on Monday, July 24th. The shares were sold at an average price of $10.93, for a total value of $361,575.33. Following the transaction, the chief operating officer now owns 644,215 shares in the company, […]
July 25, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 33,081 shares of the stock in a transaction on Monday, July 24th. The stock was sold at an average price of $10.93, for a total value of $361,575.33. Following the transaction, the chief operating officer now directly owns 644,215 shares in the company, […]
July 25, 2023
Roivant Sciences Ltd. (NASDAQ:ROIV – Get Free Report) COO Eric Venker sold 181,998 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $11.13, for a total value of $2,025,637.74. Following the sale, the chief operating officer now directly owns 644,215 shares of the […]
July 14, 2023
Benzinga Hollywood Wants To Use AI Replicas Of Actors For Eternity And Give Them Just One Day's Pay The tussle between Hollywood studios and the actors' guild SAG-AFTRA has taken a dark turn reminiscent of a Black Mirror episode – the studios want to use AI replicas of actors for eternity for the cost of just one day's pay. SAG-AFTRA (Screen Actors Guild – American Federation of Television and Radio Artists) national executive director Duncan Crabtree-Ireland reveale...
July 6, 2023
(Reuters) - Roivant Sciences Ltd is attracting interest from large pharmaceutical companies for its inflammatory bowel disease drug, Bloomberg News ...